CoChat
Sign Up
Cited by 255Lipoproteins and Cardiovascular HealthParaoxonase enzyme and polymorphismsCholesterol and Lipid Metabolism

The DOI matches its Crossref record; 26 of the 27 references it cites were found in a registry or an index.

Association Between High-Density Lipoprotein Cholesterol Levels and Adverse Cardiovascular Outcomes in High-risk Populations

Open access
Liu, Chang, Dhindsa, Devinder, Almuwaqqat, Zakaria, Ko, Yi-An, Mehta, Anurag, Alkhoder, Ayman A., Alras, Zahran, Desai, Shivang Rajan, Patel, Krishan Jignesh, Hooda, Ananya, Wehbe, Mohamad, Sperling, Laurence S., Sun, Yan V., Quyyumi, Arshed A.·2022·JAMA Cardiology
DOI 10.1001/jamacardio.2022.0912PMC PMC9118072
Open this paper in CoChat — free account

Abstract

Importance: Previous studies have shown lower cardiovascular risk with higher high-density lipoprotein cholesterol (HDL-C) levels. However, recent data in the general population have shown increased risk of adverse outcomes at very high HDL-C concentrations. Objective: To study the association between very high HDL-C levels (>80 mg/dL) and mortality in patients with coronary artery disease (CAD) and to investigate the association of known HDL-C genotypes with high HDL-C level outcomes. Design, Setting, and Participants: This prospective, multicenter, cohort study, conducted from 2006 to present in the UK and from 2003 to present in Atlanta, Georgia, recruited patients with CAD from the UK Biobank (UKB) and the Emory Cardiovascular Biobank (EmCAB), respectively. Patients without confirmed CAD were excluded from the study. Data analyses were conducted from May 10, 2020, to April 28, 2021. Exposure: High HDL-C levels (>80 mg/dL). Main Outcomes and Measures: The primary outcome was all-cause death. The secondary outcome was cardiovascular death. Results: A total of 14 478 participants (mean [SD] age, 62.1 [5.8] years; 11 034 men [76.2%]) from the UKB and 5467 participants (mean [SD] age, 63.8 [12.3] years; 3632 men [66.4%]) from the EmCAB were included in the study. Over a median follow-up of 8.9 (IQR, 8.0-9.7) years in the UKB and 6.7 (IQR, 4.0-10.8) years in the EmCAB, a U-shaped association with outcomes was observed with higher risk in those with both low and very high HDL-C levels compared with those with midrange values. Very high HDL-C levels (>80 mg/dL) were associated with increased risk of all-cause death (hazard ratio [HR], 1.96; 95% CI, 1.42-2.71; P < .001) and cardiovascular death (HR, 1.71; 95% CI, 1.09-2.68; P = .02) compared with those with HDL-C levels in the range of 40 to 60 mg/dL in the UKB after adjustment for confounding factors. These results were replicated in the EmCAB. These associations persisted after adjustment for the HDL-C genetic risk score within the UKB. Sensitivity analyses demonstrated that the risk of all-cause mortality in the very high HDL-C group was higher among men than women in the UKB (HR, 2.63; 95% CI, 1.75-3.95; P < .001 vs HR, 1.39; 95% CI, 0.82-2.35; P = .23). Conclusions and Relevance: Results of this cohort study suggest that very high HDL-C levels are paradoxically associated with higher mortality risk in individuals with CAD. This association was independent of the common polymorphisms associated with high HDL-C levels.

Overview

Integrity signals

Registry

Crossref · 10.1001/jamacardio.2022.0912

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 1

  1. Voight, 2012, Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study., Lancet, 380, 572, 10.1016/S0140-6736(12)60312-2 · DOI · Paper page

Cited by

Sorted by citations

See all 255

Related

See all

Metadata

Authors
Liu, C., Dhindsa, D., Almuwaqqat, Z., Ko, Y.-A., Mehta, A., Alkhoder, A. A., Alras, Z., Desai, S. R., Patel, K. J., Hooda, A., Wehbe, M., Sperling, L. S., Sun, Y. V., & Quyyumi, A. A.
Affiliations
Emory University (US)
ORCID
Venue
JAMA Cardiology
Publisher
American Medical Association (AMA)
Published
2022-07-01
Volume
7
Issue
7
Pages
672
ISSN
2380-6583 (ISSN-L)
DOI
10.1001/jamacardio.2022.0912
PMC
PMC9118072
OpenAlex
W4280530834
Semantic Scholar
6d4ebe822cf6955b795923be8dc61ee482ea2dae
Cited by
250
References
27
Citations by year
2026: 48 · 2025: 75 · 2024: 80 · 2023: 35 · 2022: 12
FWCI
49.42
Type
journal article
Language
en
Open access
Locations
  • JAMA Cardiology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Medical Research Council (MC_PC_17228)
  • National Institute on Aging (U54AG062334)
  • National Heart, Lung, and Blood Institute (P01HL101398, P20HL113451, P01HL086773, R61HL138657, R01HL141205, T32HL130025)
  • National Institute of Diabetes and Digestive and Kidney Diseases (P30DK111024)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Paraoxonase enzyme and polymorphisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
Keywords
cholesterol, coronary artery disease, all-cause mortality, cardiovascular mortality, U-shaped relationship, genetic variants, cardiovascular risk, vulnerable populations, cardiovascular outcomes, UK Biobank
MeSH terms
Aged, Cholesterol, Coronary Artery Disease, Female, Humans, Cholesterol, HDL, Male, Middle Aged, Prospective Studies, Risk Factors, Cohort Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review